
Keywords: autoantibodies; autoimmune bullous diseases; immunology; pemphigus; pemphigus foliaceus; pemphigus vulgaris; prediction; relapse; rituximab; Dsg1; desmoglein 1 antibody; Dsg3; desmoglein 3 antibody; EKM; extended Kaplan-Meier; PDAI; Pemphigus Disease Area